In diabetic rats, the levels of the fibrosis-related factors TGF-1, PDGF, and TIMP-1 can be decreased by renin-angiotensin-aldosterone system inhibitors, which can also be used to treat renal fibrosis (31). Here, TIMP1 is linked to renal fibrosis.